Piperine

This page as PDF · Summary

1. What Piperine Is

Piperine is the main alkaloid of black pepper and is treated in the literature together with the piperidine skeleton to which it belongs. This dual role characterises the entire literature. In safety research, isolated piperine is tested as a single dose, whereas in the majority of clinical studies it is tested as an additive to curcuminoids. Anyone reading the piperine literature is therefore usually reading literature about formulations. The substance itself is rarely made the sole variable, and it is precisely from this that the classification problems of this page arise.

For understanding almost all studies, one point is decisive: what is usually measured is not piperine, but the accompanying substance. In the controlled studies on type 2 diabetes, fatty liver and joint diseases, piperine stands in the title, yet the reported values concern blood glucose, blood lipids, inflammatory markers or quality-of-life questionnaires for the combination. No statement about piperine alone can be derived from such results. A second level is added: piperine is attributed with selective inhibition of CYP3A4, an enzyme of drug metabolism. This finding comes from studies with human cell preparations and is therefore preclinical. It is the most frequently cited explanatory pathway for altered absorption, yet it is not proof of an absorption effect in humans. Form and dose differ considerably between the studies, which further complicates cross-comparisons.

2. How Reliable the Research Is

The research is distributed unevenly. The largest block consists of basic research, followed by cell culture and animal studies; far fewer studies exist in humans, with more observational than controlled ones. The controlled studies focus on metabolism, bioavailability, inflammation and exhaustion; these are followed by safety, antioxidant questions, cardiovascular system, musculoskeletal system, oncology and bone. In oncology, reviews and mechanistic studies as well as preclinical findings dominate, while controlled human studies recede. Exhaustion is represented as an application area of the controlled literature, without a distinct research strand emerging from it.

Methodologically the field is divided in two. On one side stand randomised, double-blind and placebo-controlled studies with recurring working groups and topics that are widely cited internationally; these studies carry the more reliable statements and concern predominantly metabolism, inflammation and joint diseases. On the other side stands a broad preclinical base whose findings may only be read as such. The central methodological weakness is the combination: when piperine is given with curcuminoids or in multi-substance formulations, the single substance can no longer be isolated. Compounding this is the fact that many endpoints are laboratory values and questionnaires; disease courses and hard clinical endpoints are reported less frequently. Dose ranges and dosage forms differ between the studies, so that results can only be compared to a limited extent.

Distribution of controlled studies in humans by application area — the numbers are not additive, as one study may be assigned to several areas:

3. What Is Frequently Claimed — and What the Data Support

4. Profile: Molecule and Charge

Piperine is not a single molecule, but a mixture — there is no molecular formula and no fixed molecular mass. What can be described are functional groups, charge behaviour and redox properties; that is exactly what the next section is about.

5. Charge, Electrons, Radicals

For the charge of the piperine molecule itself, a measurement is still outstanding. The zeta potential of formulations was recorded: T-cubs with 167.00±10.49 nm particle size and a zeta potential of -34.60±0.47 mV 18, the optimised formulation FNC1 with 116.6 ± 2.13 nm and -27.9 ± 1.51 mV 21. This value describes the surface charge of the particle, not the charge of the active substance; cation exchange and electron transfer of the molecule are not the subject of investigation. Characterisation was based on particle size, zeta potential, polydispersity index, entrapment rate and in vitro release 18.

Radicals and redox behaviour were recorded primarily in cell experiments. In primary human dermal fibroblasts, an extract and its compounds GA and PP showed radical-scavenging activity in the DPPH assay and inhibited IL-1β-induced intracellular ROS formation 22 22. In PC12 cells, piperine (1 μM) lowered the intracellular ROS concentration and increased superoxide dismutase activity as well as total glutathione 19. For piperine complexed with cyclic glucans, cellular antioxidant activity was investigated 23; preclinically, mitochondrial and ROS-mediated apoptosis pathways are described 20. In humans, it would need to be clarified whether the charge state and redox behaviour of piperine can be measured directly in serum or tissue.

6. Interactions with Other Substances

With which other substances on the platform this substance has been jointly investigated or discussed in human studies and review articles — combination, comparison or shared mechanism of action. The number indicates works in which both occur.

Piperine is administered in controlled human studies together with curcuminoids to improve their oral uptake. A ratio of 100:1 6 is mentioned as well as additions of 15 mg per day 5 8, 10 mg per day 24 and 5 mg per day 15. A randomised, double-blind, placebo-controlled study over 8 weeks gave 118 participants with type 2 diabetes 1000 mg curcuminoids per day together with 10 mg piperine per day 24. Another randomised, double-blind, placebo-controlled study over 8 weeks investigated epigallocatechin gallate, capsaicins, piperine and L-carnitine as a combination in 86 overweight persons 12. In haemodialysis patients, a randomised, double-blind clinical study compared turmeric with piperine against turmeric alone 17.

In a randomised, double-blind, placebo-controlled study over 8 weeks, curcumin together with piperine showed no significant decline in PAB values compared with baseline (p = 0.06) 15. A systematic review with meta-analysis of randomised controlled studies examined the co-administration of curcumin and piperine on inflammation and oxidative stress 1. A randomised, double-blind, placebo-controlled study over 90 days with 96 obese participants tested the efficacy and safety of a curcumin preparation together with piperine 25. The evidence describes the co-administration; it contains no information on CYP enzymes, plasma protein binding or attenuation of other substances. What would need to be clarified is by which mechanism piperine alters uptake and whether it simultaneously influences the metabolism of co-administered medicinal products.

7. Overdosage, Tolerability, Limits

Two controlled human studies are available on the tolerability of piperine. In a videofluoroscopic examination, 40 patients with dysphagia swallowed bolus series to which piperine had been added as a dual TRPV1/TRPA1 agonist; the swallowing response was tested, not tolerability 11. In a randomised, double-blind and placebo-controlled study over 90 days, 96 obese participants received an extract from Cyperus rotundus together with piperine as a bioavailability enhancer; safety assessments were a secondary objective 25 25. Adverse events were not reported, and all laboratory parameters remained within the normal range 25.

Both studies tested piperine as an addition to another substance, not as a single administration. A dose from which adverse effects occur cannot be derived from this; the evidence states no quantity. Information on upper limits and on contraindications is still outstanding. The reported laboratory values come from a 90-day observation 25; longer periods have not been recorded. What would need to be clarified is how piperine alone behaves over longer periods, whether tolerability differs between various dosages and which groups of persons should be excluded from administration. A study that tests piperine as a monosubstance in increasing doses over a defined period would answer these questions.

8. The Most Robust Studies

Ordered by strength of evidence, not by familiarity: reviews and studies with many participants first. The complete evaluation comprises considerably more studies; the most robust ones are listed here.

Controlled Human Studies

• 1 The Effects of Curcumin Plus Piperine Co-administration on Inflammation and Oxidative Stress: A Systematic Review and Meta-analysis of Randomized … (2025) — Review
• Efficacy and safety of resveratrol, an oral hemoglobin F-augmenting agent, in patients with beta-thalassemia intermedia (2018) — 2,017 participants
• Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial (2017) — 118 participants
• Curcuminoids modify lipid profile in type 2 diabetes mellitus: A randomized controlled trial (2017) — 118 participants
• 2 Effects of Curcuminoids Plus Piperine on Glycemic, Hepatic and Inflammatory Biomarkers in Patients with Type 2 Diabetes Mellitus: A Randomized … (2018) — 100 participants
• 3 Curcuminoids Plus Piperine Modulate Adipokines in Type 2 Diabetes Mellitus (2017) — 118 participants
• 4 Pepper Alkaloids and Processed Meat Intake: Results from a Randomized Trial and the European Prospective Investigation into Cancer and Nutrition … (2021) — 418 participants
• Effects of curcumin supplementation on insomnia and daytime sleepiness in young women with premenstrual syndrome and dysmenorrhea: A randomized … (2023) — 124 participants
• 5 Mitigation of Systemic Oxidative Stress by Curcuminoids in Osteoarthritis: Results of a Randomized Controlled Trial (2016) — 21 participants
• 6 Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: results of a randomized … (2014) — 50 participants
• 7 Effects of Curcuminoids-Piperine Combination on Systemic Oxidative Stress, Clinical Symptoms and Quality of Life in Subjects with Chronic Pulmonary … (2016) — 45 participants
• Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial (2020) — 55 participants
• 8 Impact of Supplementation with Curcuminoids on Systemic Inflammation in Patients with Knee Osteoarthritis: Findings from a Randomized Double-Blind … (2015) — 40 participants
• 9 Curcuminoids plus piperine improve nonalcoholic fatty liver disease: A clinical trial (2019) — 70 participants
• 10 Herbal formulation "turmeric extract, black pepper, and ginger" versus Naproxen for chronic knee osteoarthritis: A randomized, double-blind … (2020)
• 11 Effect of oral piperine on the swallow response of patients with oropharyngeal dysphagia (2014)
• 12 Improvement in insulin resistance and favourable changes in plasma inflammatory adipokines after weight loss associated with two months' consumption … (2013)
• 13 Effectiveness of the piperine-supplemented Curcuma longa L. in metabolic control of patients with type 2 diabetes: a randomised double-blind … (2021) — 71 participants
• 14 Curcumin and Piperine Combination for the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind Randomized Placebo-Controlled … (2021) — 40 participants
• Ubiquitin Proteasome System Activity is Suppressed by Curcumin following Exercise-Induced Muscle Damage in Human Skeletal Muscle (2021)
• 15 The effect of curcumin with piperine supplementation on pro-oxidant and antioxidant balance in patients with non-alcoholic fatty liver disease: a … (2019) — 55 participants
• Cost-Effectiveness of Passion Fruit Albedo versus Turmeric in the Glycemic and Lipaemic Control of People with Type 2 Diabetes: Randomized Clinical … (2021)
• 16 The Effects of Curcumin Plus Piperine Supplementation in Patients with Acute Myocardial Infarction: A Randomized, Double-Blind, and … (2021) — 38 participants
• 17 Turmeric supplementation with piperine is more effective than turmeric alone in attenuating oxidative stress and inflammation in hemodialysis … (2022)

9. Summary

Proven For the combination of curcuminoids and piperine there is a systematic review with meta-analysis of randomised controlled trials on inflammation and oxidative stress (2025). Several controlled studies on the combination reported glycaemic, hepatic and inflammatory markers in type 2 diabetes, fatty liver and joint diseases; these are laboratory values, not disease courses. These results belong to the combination, not to the single substance piperine. Regarding tolerability two controlled studies in humans are available; both tested piperine as an additive to another substance. In the 90-day study with 96 obese participants no adverse events were reported and all laboratory parameters remained within the normal range.

The inhibition itself was shown in human cell preparations, thus preclinical. Hypothesis: If this role applies, the contribution of piperine should stand out more clearly where piperine is the only variable; that isolated piperine is investigable as a single dose is already shown by individual studies.

The next step would be a controlled study in which piperine is the only variable, with measurement of the uptake of the accompanying substance over a dose range. Also open is through which mechanism piperine changes the uptake and whether it influences the metabolism of simultaneously administered medicinal products. For the charge of the piperine molecule itself a measurement is still pending; so far the zeta potential of formulations has been recorded, not the charge of the active substance.

10. What Remains Open

• Dose: Which amount of isolated piperine changes the uptake of an accompanying substance to what extent, and can this be separated from the accompanying substance?
• Interactions: The preclinical shown selective CYP3A4 inhibition leaves open how isolated piperine affects the breakdown of simultaneously taken medicinal substances.
• Single substance: Controlled studies with piperine as the only variable are still pending for most areas of application; which one should be conducted first is the testable question.

11. Further Paths

Topics, pathways and chains in which this substance occurs — for all who want to look beyond the substance.

• Interaction network